Streamlining trial logistics: the RTSM architecture.

Randomization and trial supply management (RTSM) is the system used in clinical research. It assigns subjects to treatment arms, keeps blinding intact, and tracks every unit of drug supply from depot to site to subject, so a study never runs out and never dispenses the wrong thing.

Managing clinical trial logistics requires strict precision; failure to supply a site can ruin a trial, while over-allocation wastes millions in investigational products. Historically, our Client Success team had to hardcode and build the Trial Supply Management (TSM) architecture entirely from scratch for every single client and protocol.

This bespoke model created massive engineering overhead. We needed to transform a highly fragmented, custom-coded service into a productized configuration engine that clients could manage completely on their own without breaking blinding integrity or regulatory rules.

I initiated the project by conducting a comprehensive audit of our historic and active client portfolios. The data initially presented a massive fragmentation problem: the supply workflows, inventory tracking methods, and distribution logic differed wildly not only between distinct companies but even among separate studies conducted by the exact same client.

To cut through this custom operational drift, I systematically deconstructed each trial’s TSM process down to its core data parameters. By isolating the exact variables that actually triggered new custom code requests, I mapped the underlying functional overlaps.

The breakthrough moment came when I realized that this seemingly infinite variety of custom study scenarios could be synthesized into a unified, elegant system architecture. Instead of coding bespoke platforms, we could map every single clinical scenario into a predictable, 3-tiered data and inventory model based entirely on the required depth of asset serialization.

This new framework allows study setup teams to progressively scale the tracking depth based on the specific protocol complexity discovered in our research, entirely through a no-code interface.

The specific structure of the three tiers is protected under NDA, so this case study describes the architecture and its impact rather than the tier definitions themselves.

The overarching design and engineering challenge was ensuring absolute protocol blind integrity while deeply integrating inventory management into the core workflow. Working closely with the engineering team, I designed a unified experience that could support complex, variable randomization strategies, including block, stratified, and adaptive models, while maintaining a strict system boundary between allocation data and site-level interactions.

By integrating the three-tiered TSM inventory rules directly alongside the randomization engine, we created a zero-friction, single-click dispensing workflow for site coordinators. The challenge was two-fold: architecting the system so unblinding supply data remained completely segregated from the active user environment, while making automatic replenishment calculations, kit assignments, and inventory adjustments feel seamless to the user. Behind the scenes, every action remained tied directly to the FDA 21 CFR Part 11 and ICH E6(R3) audit trail.

This required design and engineering to work as one system: I defined the interaction model, user states, permissions, and workflow logic in close collaboration with engineers, while we worked through the technical architecture needed to preserve blinding, automate inventory behavior, and maintain traceability.

RTSM was the most complex systemic challenge I faced during this overhaul, and it remains the design achievement I am proudest of. Shifting the business model away from custom-coded, bespoke inventory solutions into a unified, scalable product required intensive cross-functional collaboration.

Engineering naturally analyzed the problem from data processing constraints, while I examined it through user cognitive load and protocol workflow flexibility. We spent weeks in collaborative whiteboard sessions, sketched out system topologies, mapped database schemas, walked through high-risk edge cases, and pressure-tested our ideas against all case scenarios. By the end of our discovery cycle, both departments had completely abandoned their initial assumptions.

We combined the strongest elements of both disciplines into a singular architecture that was structurally simpler for engineering to deploy, intuitive for clinical users to navigate, and flexible enough to support diverse inventory models. To validate our solution, we ran the refined framework past clients with entirely contradictory distribution processes. Every single client successfully mapped their study parameters into our 3-tier matrix without requiring a single line of custom code, validating the flexibility of the underlying model.